Category: Biosimilars
Biosimilars market research reports by GlobalData
-
Thematic Intelligence - Biosimilars in oncology
Thematic Intelligence - Biosimilars in oncology Summary Clients will gain insight into the percentage of cancer patients treated with biosimilars, the price of these agents compared to their originator, and key opinion leaders’ outlook for the products. The report includes the 8MM regulatory landsca ... Read More
-
Thematic Intelligence - The Impact of Inflation on the Healthcare Sector - H2 2023
Thematic Intelligence - The Impact of Inflation on the Healthcare Sector - H2 2023 Summary While inflationary pressures started to ease in 2023, economies continue to face uncertainty. In this Inflation in the Healthcare Sector – Physician Perspective report-tracker, GlobalData continues to examine ... Read More
-
Rheumatoid Arthritis (RA) - Competitive Landscape
Rheumatoid Arthritis (RA) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RA therapeutics. More than 13 million diagnosed prevalent cases of RA are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemio ... Read More
-
Impact of Inflation on the Healthcare Sector by Physicians Perspective, Patient Treatment, Regional Analysis, Drug Prices and Treatment Costs - Thematic Intelligence
Impact of Inflation on the Healthcare Sector by Physicians Perspective, Patient Treatment, Regional Analysis, Drug Prices and Treatment Costs - Thematic Intelligence Summary In this Inflation in the Healthcare Sector - Physician Perspective report-tracker, GlobalData continues to examine the impact ... Read More
-
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research Summary The Genomics Landscape Continues to Be Dynamic in Q2 2022 With Less Activity Seen in Immuno-oncology. The genomics landscape was active in Q2 2022, with scores increased for several companies. This includes ... Read More
-
Impact of Mexico on the Pharmaceutical Industry - Thematic Research
Impact of Mexico on the Pharmaceutical Industry - Thematic Research Summary Mexico has a large and rising middle-class population, a favorable environment for private sector investment, a rise in demand for healthcare services, and relatively high drug prices. Low-cost manufacturing of pharmaceutica ... Read More